MacDonald Valerie, Dickinson Ryan
Department of Small Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK, Canada.
J Am Anim Hosp Assoc. 2014 Jan-Feb;50(1):67-70. doi: 10.5326/JAAHA-MS-5965. Epub 2013 Nov 11.
An 8 yr old castrated male Labrador retriever mixed-breed dog with osteosarcoma (OSA) of the left proximal humerus receiving carboplatin presented 10 days after the third chemotherapy treatment with hematuria, stranguria, and pollakiuria. A presumptive diagnosis of hemorrhagic cystitis was made based on clinical signs, urinalysis, and cytologic analysis of a traumatic catheterization sample. Carboplatin was removed from the chemotherapy treatment plan and was substituted with doxorubicin. The dog was treated with meloxicam for pain, and the cystitis signs subsided over a period of 4 wk. Carboplatin is commonly used as adjuvant chemotherapy for dogs with OSA following amputation and is not known to cause hematuria in dogs, although there are reports of this occurring in humans. To the authors' knowledge, there are no reports in the veterinary literature of this toxicity.
一只8岁去势雄性拉布拉多混种犬,患有左肱骨近端骨肉瘤(OSA),正在接受卡铂化疗。在第三次化疗治疗10天后,出现血尿、排尿困难和尿频。根据临床症状、尿液分析以及经尿道插管样本的细胞学分析,初步诊断为出血性膀胱炎。卡铂被从化疗方案中移除,换用阿霉素。该犬用美洛昔康止痛,膀胱炎症状在4周内逐渐消退。卡铂通常用作犬骨肉瘤截肢术后的辅助化疗药物,虽然有报告称其在人类中会导致血尿,但在犬类中尚无此报道。据作者所知,兽医文献中没有关于这种毒性的报道。